Denali Therapeutics is a biopharmaceutical company in the United States that specializes in developing products for neurodegenerative diseases like Parkinson's, ALS, and Alzheimer's. The company is involved in clinical trials for various treatment options, including one for cutaneous lupus erythematosus in phase II. Denali Therapeutics also has several collaboration and research agreements with pharmaceutical companies, research institutions, and medical foundations.